People: Hansen Medical Inc (HNSN.O)

HNSN.O on Consolidated Issue listed on NASDAQ Global Market

1.25USD
23 Jul 2014
Price Change (% chg)

$0.03 (+2.05%)
Prev Close
$1.22
Open
$1.22
Day's High
$1.25
Day's Low
$1.22
Volume
272,311
Avg. Vol
517,804
52-wk High
$2.89
52-wk Low
$1.10

Search Stocks

Summary

Name Age Since Current Position

Michael Eagle

66 2012 Lead Independent Chairman of the Board

Cary Vance

48 2014 President, Chief Executive Officer, Director

Christopher Lowe

46 2014 Interim Chief Financial Officer, Director

William Sutton

49 2013 Chief Operating Officer

Robert Cathcart

54 2013 Senior Vice President - Global Sales

Joseph Guido

48 2012 Vice President - Marketing and Business Development

Susan Leonard

51 2012 Vice President - Human Resources

Rita Jacob

54 2010 Vice President - Clinical Affairs and Training

Marjorie Bowen

49 2013 Independent Director

Kevin Hykes

48 2009 Independent Director

Stephen Newman

63 2012 Independent Director

William Rohn

70 2012 Independent Director

Jack Schuler

73 2013 Independent Director

Will Weinstein

73 2013 Independent Director

Nadim Yared

46 2012 Independent Director

Biographies

Name Description

Michael Eagle

Mr. Michael L. Eagle is Lead Independent Chairman of the Board of Hansen Medical, Inc. Mr. Eagle previously served as the Vice President of Global Manufacturing for Eli Lilly and Company from 1993 through 2001 and held a number of executive management positions with Eli Lilly and Company and its subsidiaries throughout his career there. Since retiring from Eli Lilly and Company, he has been a founding member of Barnard Life Sciences, LLC, a life sciences consulting company. Mr. Eagle is a member of the board of directors and serves on the audit committee of Cadence Pharmaceuticals, Inc., a biopharmaceutical company, and is a member of the board of directors and serves on the audit and compensation committees of Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company. Mr. Eagle holds a B.M.E. from Kettering University and an M.S.I.A. from Purdue University. Mr. Eagle’s more than forty years of experience in executive management and engineering, primarily focused on the manufacture of pharmaceutical products and medical devices, and his experience on the boards of other public companies contributed to our conclusion that he should serve as a director.

Cary Vance

Mr. Cary Vance is President, Chief Executive Officer, Director of Hansen Medical, Inc., since May 23, 2014. He has served as President of Anesthesia & Respiratory Care at Teleflex, Inc., a public medical device manufacturer, since May 2011, and previously served as its Executive Vice President, North America from February 2010 through May 2011. Prior to joining Teleflex, he served as the Vice President, Interventional Oncology at Covidien, a global healthcare products company, from 2008 to February 2010, and as its Vice President and General Manager of the US Region for Energy-based Devices from 2007 to 2008. Prior to Covidien, Mr. Vance served in a number of roles at GE Healthcare from 1997 to 2007, principally in diagnostic imaging equipment sales and sales management. Mr. Vance received a B.A. in Economics and Philosophy, and a Masters of Business Administration, from Marquette University. Mr. Vance’s prior experience as a senior executive of other medical device and healthcare companies and his role as our Chief Executive Officer contributed to our conclusion that he should serve as a director.

Christopher Lowe

Mr. Christopher P. Lowe is an Interim Chief Financial Officer, Director of Hansen Medical, Inc. Mr. Lowe has served as a member of our Board of Directors since September 2006 and previously served as our interim Chief Executive Officer from February 2014 to May 2014. Mr. Lowe served as Vice President, Administration and Chief Financial Officer of Anthera Pharmaceuticals, Inc., a drug development company, from November 2007 through June 2013, and additionally served as its Chief Business Officer from January 2011 until June 2013. Since leaving Anthera, Mr. Lowe was an independent consultant to life sciences companies until joining FLG Partners, LLC, a CFO consulting, services and board advisory firm, as a partner in January 2014. Mr. Lowe served as Vice President, Finance and Administration of Asthmatx, Inc., a medical device company, from September 2005 to December 2005 and as its Chief Financial Officer from January 2006 to November 2007. Mr. Lowe holds a B.S. from California Polytechnic State University, San Luis Obispo and an M.B.A. from Saint Mary’s University, Texas.

William Sutton

Mr. William Sutton is Chief Operating Officer of Hansen Medical Inc. Mr. Sutton has over 25 years of product development and manufacturing experience in the medical technology industry. Prior to joining the Company, Mr. Sutton served in increasingly senior positions at St. Jude Medical over the past ten years, including most recently as Vice President of Research and Development of the Atrial Fibrillation (“AF”) Division since September 2006. Earlier in his tenure at St. Jude Medical, he served as Vice President of Program Management and Site Manager of the AF Division and as Director for research and development for the Cardiac Surgery Division. Prior to St. Jude Medical, Mr. Sutton held executive management positions in research and development and manufacturing at Vascular Solutions, Urologix and C.R. Bard. Mr. Sutton began his career as a development engineer in the Diagnostics Division of Abbott Labs, and holds a B.S. and M.S. in mechanical engineering from Stanford University.

Robert Cathcart

Mr. Robert Cathcart is Senior Vice President - Global Sales of Hansen Medical Inc. Prior to joining Hansen, Mr. Cathcart served as the Chief Commercial Officer of HyperBranch Medical Technology, a surgical medical device company, from October 2011 until April 2012. From April 2009 to August 2011, he served as the President and CEO of FlowCo, Inc./3DT Holdings, a privately-held medical device company focused on interventional cardiology. From 2001 to 2009, Mr. Cathcart worked at Datascope Corporation (acquired by Maquet); where he served as the Division President and Vice President of Sales in the Cardiac Assist Division, and later the President of the Interventional Products Division. Mr. Cathcart has also led the sales functions of Promedix Inc., Bard Access Systems and MedChem Products. He began his career at Davis + Geck, where he served as a sales representative, global training manager, regional manager, and eventually area director of the endo-surgery division. Mr. Cathcart holds a Bachelor of Arts degree from DePauw University.

Joseph Guido

Mr. Joseph Guido is Vice President - Marketing and Business Development of Hansen Medical, Inc. Prior to joining Hansen, from July 2011 to November 2011, Mr. Guido served as the President of Heartstitch Medical, a medical devices company. From May 2006 to October 2010, Mr. Guido was Vice President of Sales and Marketing at Novare Surgical Systems, Inc., a privately-held medical device company that developed innovative products for minimally invasive surgery. Previous to Novare, he was the Director of Global Strategic Marketing for Abbott Vascular Devices’ vessel closure business, and Vice President of Global Marketing at Intuitive Surgical, a public medical device company specializing in surgical robotic systems. Mr. Guido has a Bachelor of Science degree in Business Administration from Villanova University and a Master’s degree in Business Administration from Pepperdine University.

Susan Leonard

Ms. Susan Leonard is Vice President - Human Resources of Hansen Medical Inc. She has nearly 20 years of experience in human resources working and consulting for medical technology companies throughout the Bay Area. From 1998 through 2012, Ms. Leonard worked as Owner and Principal Consulting for Susan Leonard Consulting. Ms. Leonard has also held HR management positions for numerous companies including First Medical, Inc., Guidant and ACS, and Working Assets Funding Service. Ms. Leonard has a bachelor’s degree in economics from University of California, Berkeley and an MBA from Columbia University.

Rita Jacob

Ms. Rita V. Jacob is Vice President - Clinical Affairs and Training of Hansen Medical, Inc. Ms. Jacob has more than 20 years of experience in training, technical support and collaboration with vascular surgeons and interventionalists. From April 2009 to December 2010, prior to joining Hansen, Ms. Jacob was Director, Clinical Affairs, Vascular Therapies for Covidien. From June 2006 to April 2009, Ms. Jacob served as Vice President, Clinical Affairs at Bacchus Vascular, Inc. Prior to joining Bacchus she helped design and manage training and clinical research of AAA (abdominal aortic aneurysm) stent grafts for Medtronic and Boston Scientific Corporation. Earlier in her career she held multiple clinical, sales and related functional positions with Guidant and ACS. Ms. Jacob has a bachelor of science degree in nursing from the University of Maryland and is a registered nurse.

Marjorie Bowen

Ms. Marjorie L. Bowen is Independent Director of Hansen Medical, Inc. Ms. Bowen is an experienced public and private company director who is a qualified financial expert and is well versed in corporate governance matters. In addition to Hansen, Ms. Bowen has served as a director for four publicly listed companies (Dune Energy and Illinois Power Generating Co., and previously, Talbots, and Texas Industries, Inc.) as well as four privately held companies. Ms. Bowen’s directorships follow a nearly 20 year career in investment banking at Houlihan Lokey, advising boards of public companies on transactional, strategic and other shareholder matters, and heading the firm’s industry leading fairness opinion practice. During her nearly two decades at Houilhan Lokey Ms. Bowen was an active deal advisor to public company boards, a product and practice leader, as well as a member of the firm’s senior management. Ms. Bowen has amassed a broad base of experience on virtually every type of corporate finance transaction for both healthy and distressed companies. Ms. Bowen holds a B.A. from Colgate University and an M.B.A. from the University of Chicago. The Board appointed Ms. Bowen as a director in 2013 due to, among other things, her nearly 25 years of experience in advising both public and private companies as an investment banker and corporate director.

Kevin Hykes

Mr. Kevin Hykes is Independent Director of Hansen Medical Inc. Mr. Hykes is currently an Operating Partner at Versant Ventures and the Chairman and CEO of Metavention, Inc., an early-stage medical device company focused on the development of interventional therapies for the treatment of type 2 diabetes. From March 2010 until December 2012, Mr. Hykes was the President and Chief Executive Officer at Cameron Health, Inc., an implantable defibrillator company, which was acquired by Boston Scientific Corporation in June 2012. From May 2008 to March 2010, Mr. Hykes served as the Chief Commercial Officer at Visiogen, Inc., a developer of products for cataract and refractive patients, which was acquired by Abbott Laboratories in October 2009. Previously, Mr. Hykes was employed by Medtronic, Inc., from 1992 to 2008, including as Vice President, Healthcare Systems, from December 2005 to May 2008 and as Vice President, Heart Failure Business, from May 2003 to December 2005. Mr. Hykes holds a B.A. in Business Administration from the University of Wisconsin, Madison and an M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University.

Stephen Newman

Dr. Stephen L. Newman, M.D. is Independent Director of Hansen Medical, Inc. Having served in increasingly senior positions at Tenet Healthcare Corporation over the past 14 years, Dr. Newman has extensive healthcare operations experience. In his recently completed role as Vice Chairman, Dr. Newman led Tenet’s health information technology project deployment, the company’s medical staff development efforts and its quality, safety and service initiative. Prior to his appointment to Vice Chairman in January 2012, Dr. Newman served as Corporate Chief Operating Officer, Executive Vice President, for five years, where his responsibilities included strategic and operational oversight of Tenet’s 49 hospitals and 100 ambulatory and imaging centers. Before his tenure at Tenet, Dr. Newman served as President and Chief Executive Officer of HCA’s Louisville HealthCare Network, where he had operating responsibilities for three hospitals and 3,000 employees within a $500 million business. Dr. Newman currently serves on the board of directors of Cadence Pharmaceuticals, Inc. and is member of its nominating and corporate governance committee. Dr. Newman served on the board of directors of Optimer Pharmaceuticals, Inc. from 2012 through October 2013, and was a member of its audit committee, compensation committee and nominating and corporate governance committee. Dr. Newman also currently serves on the Federal Reserve Bank of Atlanta’s Labor, Education and Healthcare Council and recently completed a five year term on the Board of Directors of the Federation of American Hospitals. Dr. Newman holds an MBA from Tulane University’s AB Freeman School of Business, an M.D. from the University of Tennessee Center for Health Sciences and a Bachelor’s degree from Rutgers University.

William Rohn

Mr. William R. Rohn is Independent Director of Hansen Medical Inc. Mr. Rohn served as Chief Operating Officer of Biogen Idec, the successor company to IDEC Pharmaceuticals, a biotechnology company, from 2003 until 2005. From 1998 until 2003, Mr. Rohn was President and Chief Operating Officer of IDEC Pharmaceuticals, a biotechnology company. Mr. Rohn joined IDEC in 1993 as Senior Vice President, Commercial and Corporate Development and was appointed Senior Vice President, Commercial Operations in 1996. From 1985 until 1993, Mr. Rohn was employed by Adria Laboratories, a pharmaceutical company that has since been acquired by Pfizer Inc., most recently as Senior Vice President of Sales and Marketing. Mr. Rohn is a director of Sophiris Bio Inc. and private entities. Mr. Rohn holds a Bachelor’s degree in Marketing from Michigan State University and completed graduate-level coursework in Business Administration at Indiana State University.

Jack Schuler

Mr. Jack W. Schuler has served as an Independent Director of Hansen Medical, Inc., since August 2013. Mr. Schuler is a co-founder and partner in Crabtree Partners LLC, a private investment firm in Lake Forest, IL. Mr. Schuler worked for Texas Instruments from 1964 to 1972 in France, Germany, and Japan. From 1972 to 1989, he was employed by Abbott Laboratories in various positions, the last four years as President and Chief Operating Officer. He currently serves on the board of directors for Accelerate Technologies, Quidel Corporation, and Stericycle and is a trustee of Carleton College. He received a B.S. degree in Mechanical Engineering from Tufts University and an M.B.A. degree from Stanford University Graduate School of Business Administration. The Board appointed Mr. Schuler as a director in 2013 due to, among other things, his experience as both a medical device executive and an investor and advisor to medical device companies and due to the Company’s obligations under a rights agreement with certain investors in the Company’s August 2013 private placement financing. See “Previous Selection of Directors.”

Will Weinstein

Mr. Will K. Weinstein is Independent Director of Hansen Medical, Inc. Currently, Mr. Weinstein serves as a Financial and Investment Advisor and Money Manager to a number of individuals and corporations active in the equity markets. He is also a limited partner of Conifer Securities in San Francisco. Mr. Weinstein was a Governor of the Midwest Stock Exchange for five years, and also served for five years as a Governor of the American Stock Exchange until its merger with Nasdaq in 1998. Mr. Weinstein was Chairman and CEO of Genesis Merchant Group Securities in San Francisco from 1989 until it was sold in 1997. He then started and managed a hedge fund and two private equity partnerships. Prior to Genesis, he was the Investment and Financial Policy Advisor to the Pritzker family in Chicago. Previously, Mr. Weinstein was the Managing Partner of Montgomery Securities in San Francisco and Chairman of its Investment Policy Committee. He was also a member of the Executive Committee of Oppenheimer and Co. and its partner in charge of trading in the 1970’s. Mr. Weinstein is a member of the board of directors of the Osher Center for Integrative Medicine in San Francisco, and he recently joined the board of the San Francisco State University Foundation, where he is a member of the endowment and athletic committees. Mr. Weinstein’s previous board affiliations include DHL Incorporated, Butterfield & Butterfield, Beverly Enterprises, Mt. Zion Hospital, the San Francisco Chapter of the Juvenile Diabetes Research Foundation, the San Francisco Performances, the Robert H. Lurie Comprehensive Cancer Center, the UCSF Department of Prostate Cancer Advocacy Core and the City College of San Francisco Foundation.

Nadim Yared

Mr. Nadim Yared is Independent Director of Hansen Medical, Inc. Mr. Yared’s career in the medical device industry has spanned nearly 20 years. He currently serves as the President and Chief Executive Officer of CVRx, Inc., a privately-held medical device company developing the Barostim neo™ system, an active implantable device for the treatment of hypertension and heart failure. During his seven years in this position, Mr. Yared has helped CVRx raise significant funding to develop the company’s next generation technology and conduct clinical trials. Preceding his term at CVRx, Mr. Yared served as Vice President and General Manager of Medtronic, Inc. for four years. During his tenure, he directed sales, marketing, business development, product/technology development and manufacturing of surgical medical imaging products. Until 2002, Mr. Yared held increasingly senior positions at GE Medical Systems over a period of nine years. Much of his focus during this time was medical device sales and marketing management. Mr. Yared also currently serves on the boards of the medical device industry trade group, AdvaMedand te medical device innovation consortium, MDIC, a public-private partnership. Mr. Yared holds an M.B.A. from Insead in Paris France, and an engineering degree from Ecole Nationale Superieure des Telecommunications.
Search Stocks